Mutations in the mismatch repair genes MLH1, MSH2, MSH6, or PMS2, which are associated with Lynch Syndrome, represent an 8.6-fold increased risk of pancreatic cancer [41]. This evidence concerns the gene MSH6 and pancreatic neoplasm.